Glucagon-like Peptides (GLP-1) Perspectives in Synucleinopathies Treatment.
Mov Disord Clin Pract · 2018
Last updated 2026-08-28| Journal | Mov Disord Clin Pract, 2018 |
|---|---|
| Citations | 7 |
| Relative citation ratio | 0.35 |
| NIH percentile | 21 |
| Molecules | — |
Full record and abstract on PubMed 30800701 ↗